Skip to main content
Log in

Detection of carriers for duchenne muscular dystrophy. Quality control of creatine kinase assay

  • Original Invesigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

A report by Bullock and coworkers has emphasized the need for standardization of the CK assay in carrier detection for DMD. A collaborative study, according to a well-specified design and involving two laboratories in Paris and Lyon, indicates that the reliability of this assay can be improved provided that special attention is paid to information about participating subjects, laboratory protocol, and repeated sampling. On a random sample of young women, mean and variance of 1n(CK) are 1.66 and 0.015 respectively. Within and between variance components are in a 3:4 ratio, homogeneous between populations. Additional use of a common test serum should insure good reliability of this assay among laboratories.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adornato BT, Kager LJ, Engel WK (1978) Myoglobinemia in Duchenne muscular dystrophy patients and carriers: a new adjunct to carrier detection. Lancet 2:499–501

    Article  CAS  PubMed  Google Scholar 

  • Bullock DG, McSweeney FM, Whitehead TP, Edwards JH (1979) Serum creatine kinase activity and carrier status for Duchenne muscular dystrophy. Lancet 2:1370

    Article  CAS  PubMed  Google Scholar 

  • Burt D, Emery AEH (1979) Serum LDH-5 carrier of Duchenne muscular dystrophy. Neurology (Minneap) 2:239–241

    Article  Google Scholar 

  • Carter CO (1979) Carrier detection in Duchenne muscular dystrophy. Lancet 1:979

    Article  CAS  PubMed  Google Scholar 

  • Commission “Enzymologie”. Comité Scientifique de la Société Française de Biologie Clinique (1980) Modification d'une méthode recommandée pour la mesure de la concentration catalytique de la créatine kinase dans le sérum humain à 30°C. Document C' stade II.. Ann Biol Clin 3:191–197

    Google Scholar 

  • Davie AM, Emery AEH (1978) Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet 15: 339–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dreyfus JC, Schapira G, Demos J, Alexandre Y (1960) Etude de la créatine kinase sérique chez les myopathes et leurs familles. Rev Fr Et Clin Biol 5:384–386

    CAS  Google Scholar 

  • Emery AEH, Burt D, Dubowitz V, Rocher I, Donnai D, Harris R, Donnai P (1979) Antenatal diagnosis of Duchenne muscular dystrophy. Lancet 1:847–849

    Article  CAS  PubMed  Google Scholar 

  • Golbus MS, Stephens JD, Mahoney MJ, Haseline TP, Caskey CT, Banker BG (1979) Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. Lancet 2: 1251

    Google Scholar 

  • Hartley HO, Rao JNK (1967) Maximum likelihood estimation for the mixed analysis of variance model. Biometrika 54:93–108

    Article  CAS  PubMed  Google Scholar 

  • Ionasescu V, Zellweger H, Burmeister L (1976) Detection of carrier and genetic counselling in DMD by ribosomal protein synthesis. Acta Neurol Scand 54:442–452

    Article  CAS  PubMed  Google Scholar 

  • Ionasescu V, Zellweger H, Caucilla P (1979) Fetal serum phosphokinase not a valid predictor of Duchenne muscular dystrophy. Lancet 2: 1251

    Google Scholar 

  • Lalouel JM (1979) GEMINI: a computer program for optimization of non-linear functions. department of Biophysics and Medical Computing, Technical Report no. 14, University of Utah, Salt Lake City, Utah

    Google Scholar 

  • Miyoshi K, Saito S, Kawai H, Kondo A, Iwasa M, Hayashi T, Yagita M (1978) Radioimmunoassay for human myoglobin: methods and results in patients with skeletal muscle or myocardial disorder. J Lab Clin Med 92:341–352

    CAS  PubMed  Google Scholar 

  • Morton NE, Lalouel JM (1979) Genetic counseling in sex linkage. Birth Defects 15:9–24

    CAS  PubMed  Google Scholar 

  • Percy ME, Chang LS, Murphy EG, Oss I, Verelen-Dumoulin C, Thompson M (1979) Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle Nerve 2: 329–339

    Article  CAS  PubMed  Google Scholar 

  • Percy ME, Andrews DF, Thompson MW (1981) Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexine in combination. Am J Med Genet 8:397–409

    Article  CAS  PubMed  Google Scholar 

  • Roses AD, Roses MJ, Nicholson GA, Nicholson GA, Roe CR (1977) Lactate deshydrogenase isoenzyme 5 in detecting carriers of Duchenne muscular dystrophy. Neurology (Minneap) 27:414–427

    Article  CAS  Google Scholar 

  • Stern CMM, Kaman MC, Dubowitz V (1979) Lymphocyte capping in Duchenne muscular dystrophy. Lancet 1:1300–1301

    Article  CAS  PubMed  Google Scholar 

  • Zatz M, Otto P (1980) Effect of age on the detection rate in Duchenne muscular dystrophy. J Neurol Sci 47:407–410

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plauchu, H., Junien, C., Maire, I. et al. Detection of carriers for duchenne muscular dystrophy. Quality control of creatine kinase assay. Hum Genet 61, 205–209 (1982). https://doi.org/10.1007/BF00296443

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296443

Keywords

Navigation